Escort aptamers: a delivery service for diagnosis and therapy.
about
A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichmentSmart functional nucleic acid chimeras: enabling tissue specific RNA targeting therapyEmerging clinical applications of RNARNA Aptamer That Specifically Binds to Mycolactone and Serves as a Diagnostic Tool for Diagnosis of Buruli UlcerDrug delivery systems in urology--getting "smarter".Nucleic acid aptamers in cancer medicine.Selection, characterization and application of new RNA HIV gp 120 aptamers for facile delivery of Dicer substrate siRNAs into HIV infected cellsMultitasking by multivalent circular DNA aptamers.RNA aptamers as reversible antagonists of coagulation factor IXa.Aptamer-targeted cell-specific RNA interferenceCatalytic DNAs as potential therapeutic agents and sequence-specific molecular tools to dissect biological function.Nucleic acid aptamers: clinical applications and promising new horizonsTherapeutic applications of transcription factor decoy oligonucleotidesA SELEX-screened aptamer of human hepatitis B virus RNA encapsidation signal suppresses viral replication.Bioengineering strategies for designing targeted cancer therapiesCell-specific aptamer-mediated targeted drug deliveryNucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicineTetraspanins as regulators of the tumour microenvironment: implications for metastasis and therapeutic strategies.Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2RNA aptamer probes as optical imaging agents for the detection of amyloid plaques.In vivo imaging with oligonucleotides for diagnosis and drug development.Nucleic acid aptamers as tools and drugs: recent developments.Hydrophobization and bioconjugation for enhanced siRNA delivery and targetingCarrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group.Electrical detection of cancer biomarker using aptamers with nanogap break-junctions.Nanoparticle-aptamer bioconjugates for cancer targeting.Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy.Ligand-based targeted therapy for cancer tissue.Aptamers and aptamer targeted delivery.Peptide- and aptamer-functionalized nanovectors for targeted delivery of therapeutics.Application of locked nucleic acids to improve aptamer in vivo stability and targeting functionTargeted delivery of CRISPR/Cas9 to prostate cancer by modified gRNA using a flexible aptamer-cationic liposome.Recent advances in ligand targeted therapy.Chimeric aptamers in cancer cell-targeted drug deliveryEscort aptamers: new tools for the targeted delivery of therapeutics into cells.Use of RNA in drug design.Characterisation of aptamers for therapeutic studies.Tenascin-C aptamers are generated using tumor cells and purified protein.Isolation and characterization of 2'-amino-modified RNA aptamers for human TNFalpha.Aptamer-conjugated polymeric nanoparticles for targeted cancer therapy.
P2860
Q24618342-C70AE5DC-3EFD-4F26-B6C9-C69E31B0D645Q27025832-F51AB6E2-828B-4782-B28B-8195EB1D2863Q28214164-97D4C5CF-0E37-47C8-B944-2BC1144611BBQ28552925-54FCDA59-9222-4FCF-8254-AC3BDC630226Q30478170-161F44C3-C66E-4BB3-9917-A96A921BD70AQ30854890-E7576DA0-B433-414A-AD93-DA11B61E04F4Q30859838-C65D233D-100A-4C59-85B3-BC111B2330F5Q33234113-148CCEF1-FCDB-49B1-8446-F83B7E107E56Q33344114-B61F72E5-D6FA-4602-9647-BD96F1B4C92FQ33717239-C27FD29A-6E10-4C47-B632-2465FDD16FBEQ33925818-95AF6C0A-52A3-42B0-BBBD-843DA3E3D416Q34028112-9CE05EC6-E7A7-4722-91BF-D16EDD82F373Q34078075-E27A8EDE-D1C9-4DD0-AF81-4E41F9EEA245Q34085801-5D2C848A-6FE6-4652-9864-D63D1FC9360DQ34194191-298861F8-D262-4A79-8AC6-0A38C9243F46Q34599718-2462712E-E260-4DAD-AE6A-771247151A7EQ34698624-63CF4759-44C7-49B4-8E66-BD194F6870E4Q34914039-3CC67514-9E88-4E2B-8B13-73DB69402219Q34981750-995E4029-F0AB-4BF1-B29E-5465E881DECDQ35108312-FD2D3A2D-BD01-4BDE-B570-6982F95E67DDQ35127223-EC7CBD64-5E7A-47FD-ADFE-3F8C59FED446Q35549348-A7A304F1-1808-4043-B3E1-B1328E0CBFA0Q35697443-FAD69909-CD7B-4A8A-BBE6-986E6A916E0DQ35823611-789F419B-806D-4902-B6F7-B2B5E684B7F4Q36116287-A1200D8D-A6B0-49E8-89BD-E157180FFE9AQ36460842-4882F0D5-3137-43EA-BB05-DECCE2F29CC9Q37305770-E528DADB-8D65-409D-996F-47E84AA77A65Q37425224-6FFA768A-FEEF-49A9-A949-71D3050E5893Q37490756-E4AAFC7B-EBCB-425E-8C7E-152875826BB4Q37572760-3C3FC429-2E6F-4DFB-B683-E28C43F880D4Q37619467-DFD0A8BF-98F3-42D7-8D3A-28D4F9B347A5Q37705970-87C3A72D-2298-4674-9185-B94F34685F92Q37937611-A7C51E87-1CBE-4D15-A709-B43500B51C4EQ37939984-242E8932-5D85-4C41-8DC5-13A0BF236ED3Q38014851-7BD29E6C-76D8-4800-90D4-8E5192B5ACB1Q38089160-3F91DF67-F23B-4371-9631-558631D9E9BCQ38089865-6C45AF74-8D02-42DF-A091-0DC78B43B6A1Q38296050-EC90D76E-D306-4325-8106-4D7C50448E5BQ38332501-07A769E2-35EE-472B-BC35-0089F40B114CQ38383216-5424A52A-CCA2-46C9-8F17-FB91CF8C5071
P2860
Escort aptamers: a delivery service for diagnosis and therapy.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Escort aptamers: a delivery service for diagnosis and therapy.
@en
type
label
Escort aptamers: a delivery service for diagnosis and therapy.
@en
prefLabel
Escort aptamers: a delivery service for diagnosis and therapy.
@en
P2860
P356
P1476
Escort aptamers: a delivery service for diagnosis and therapy.
@en
P2093
P2860
P304
P356
10.1172/JCI11324
P407
P577
2000-10-01T00:00:00Z